Keywords: خط دوم درمان; Status epilepticus; Fosphenytoin; Midazolam; Acute encephalopathy; Safety; Second-line treatment; Consciousness; Respiratory depression;
مقالات ISI خط دوم درمان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: خط دوم درمان; Autoimmune Liver Diseases; Steroid-Induced Side Effects; Second-Line Treatment; Bone Density; AASLD; American Association of the Study of Liver Diseases; AIH; autoimmune hepatitis; ALT; alanine aminotransferase; DXA; dual-energy X-ray absorptiometry; EASL
Keywords: خط دوم درمان; Non-small cell lung cancer; Chemotherapy; Second-line treatment; Docetaxel; Pemetrexed; Erlotinib;
Keywords: خط دوم درمان; Advanced pancreatic adenocarcinoma; Second-line treatment; Clinical trials; Nanoliposomal irinotecan;
Keywords: خط دوم درمان; Immune thrombocytopenia; Autoimmune hemolytic anemia; Thrombotic thrombocytopenic purpura; Splenectomy; Second-line treatment;
Keywords: خط دوم درمان; Anti-PD-1 antibody; Immunotherapy; Nivolumab; PD-L1; Second-line treatment;
Keywords: خط دوم درمان; Active SSc-ILD; First-line treatment; Second-line treatment
Keywords: خط دوم درمان; Hepatocellular carcinoma; Metronomic capecitabine; Second-line treatment;
Keywords: خط دوم درمان; Advanced urothelial carcinoma; Intermediate endpoint; Overall survival; Progression-free survival at 6 months; Second-line treatment
Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology
Keywords: خط دوم درمان; Chemotherapy; Combination strategies; Immunotherapy; Second-line treatment; Targeted therapies;
Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061)
Keywords: خط دوم درمان; SCLC; Sunitinib; Tyrosine kinase inhibitor; Targeted therapy; Phase II study; Second-line treatment;
Retrospective efficacy and safety analyses of erlotinib, pemetrexed, and docetaxel in EGFR-mutation-negative patients with previously treated advanced non-squamous non-small-cell lung cancer
Keywords: خط دوم درمان; EGFR mutation-negative; Non-squamous non-small-cell lung cancer; Erlotinib; Pemetrexed; Docetaxel; Performance status; Second-line treatment;
A comparison of individualized treatment guided by VeriStrat with standard of care treatment strategies in patients receiving second-line treatment for advanced non-small cell lung cancer: A cost-utility analysis
Keywords: خط دوم درمان; VeriStrat; Second-line treatment; Non-small cell lung cancer; Cost-utility analysis; Epidermal growth factor receptor inhibitor; Markov model;
Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent/metastatic head and neck cancer patients
Keywords: خط دوم درمان; Head and neck cancer; Recurrent/metastatic; Paclitaxel plus cetuximab; Second-line treatment; Retrospective
Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: A phase II multicenter study of the Hellenic Oncology Research Group
Keywords: خط دوم درمان; Small-cell lung cancer; Chemo-resistance; Paclitaxel; Bevacizumab; Salvage treatment; Second-line treatment
Prognostic score for second-line chemotherapy of advanced non-small-cell lung cancer: External validation in a phase III trial comparing vinflunine with docetaxel
Keywords: خط دوم درمان; Advanced NSCLC; Second-line treatment; Prognostic score; Vinflunine; Docetaxel; Validation; Performance status; Response to first-line
Phase II study of biweekly cetuximab in combination with irinotecan as second-line treatment in patients with platinum-resistant gastro-oesophageal cancer
Keywords: خط دوم درمان; Cetuximab; Irinotecan; Second-line treatment; Stomach cancer
Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: A mono-institutional experience
Keywords: خط دوم درمان; Malignant pleural mesothelioma; Platinum-based chemotherapy; Gemcitabine; Second-line treatment; Third-line treatment; Clinical benefit;
Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: A multi-institutional retrospective analysis
Keywords: خط دوم درمان; Small-cell lung cancer; Second-line treatment; Chemotherapy; Topotecan; Platinum-based rechallenge; Retrospective analysis;
Cabazitaxel: Evidence and clinical experience
Keywords: خط دوم درمان; Prostate; Castrate-resistant prostate cancer; Docetaxel; Second-line treatment; Cabazitaxel; Abiraterone; Toxicity; Performance status;
Prognostic Factors in Second-Line Treatment of Urothelial Cancers With Gemcitabine and Paclitaxel (German Association of Urological Oncology Trial AB20/99)
Keywords: خط دوم درمان; Urothelial cancer; Second-line treatment; Prognostic factors
Cutaneous lupus erythematosus: Update of therapeutic options : Part II
Keywords: خط دوم درمان; biologics; dapsone; lupus erythematosus; methotrexate; mycophenolate mofetil; retinoids; second-line treatment; skinACLE, acute cutaneous lupus erythematosus; CHLE, chilblain lupus erythematosus; CLE, cutaneous lupus erythematosus; DILE, drug-induced lupu
Second-line weekly paclitaxel in resistant or relapsed non-small cell lung cancer treated with docetaxel and carboplatin: A multi-center phase II study
Keywords: خط دوم درمان; Non-small cell lung cancer; Chemotherapy; Second-line treatment; Paclitaxel; Cross-resistance
Traitement de seconde ligne dans le mésothéliome pleural malin. Ãtude rétrospective française (2005-2006)
Keywords: خط دوم درمان; Mésothéliome pleural malin; Traitement de seconde ligne; Chimiothérapie; Thérapie moléculaire ciblée; Faisabilité; Malignant pleural mesothelioma; Second-line treatment; Chemotherapy; Targeted therapy; Feasibility;
Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer
Keywords: خط دوم درمان; Non-Small Cell Lung Cancer; Metastases; Brain localization; Pemetrexed; Chemotherapy; Second-line treatment
Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: A prognostic score from individual data of nine randomised trials
Keywords: خط دوم درمان; Non-small-cell lung cancer; Second-line treatment; Prognostic factors; Prognostic score; Pooled analysis
Advanced gastric cancer – Slow but steady progress
Keywords: خط دوم درمان; Gastric cancer; Chemotherapy; Salvage; Molecular targets; Prognostic index; Second-line treatment
Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication
Keywords: خط دوم درمان; H. pylori; Levofloxacin; Second-line treatment
Pemetrexed as Second-Line Treatment in Malignant Pleural Mesothelioma after Platinum-Based First-Line Treatment
Keywords: خط دوم درمان; Alimta; Pemetrexed; Pleural mesothelioma; Second-line treatment;
Ãtude de phase 2, randomisée, évaluant une polychimiothérapie orale (CCNU, Cyclophosphamide, étoposide) et une polychimiothérapie intraveineuse dans les cancers bronchiques à petites cellules en seconde ligne en rechute (essai GFPC0501)
Keywords: خط دوم درمان; Cancer à petites cellules; Chimiothérapie; Récidive; Phase II randomisée; Small-cell lung cancer; Second-line treatment; Chemotherapy; Randomized trial;
Phase II trial of carboplatin and paclitaxel in non-small cell lung cancer patients previously treated with chemotherapy
Keywords: خط دوم درمان; Non-small cell lung cancer; Carboplatin; Paclitaxel; Chemotherapy; Second-line treatment; Toxicity
Treatment of Helicobacter pylori
Keywords: خط دوم درمان; antibiotic resistance; antibiotics; eradication failure; eradication; Helicobacter pylori; rescue therapy; second-line treatment
Sequential prolonged oral topotecan and prolonged oral etoposide as second-line therapy in ovarian or peritoneal carcinoma: A phase I Gynecologic Oncology Group study
Keywords: خط دوم درمان; Topotecan; Etoposide; Dose-limiting toxicities; Second-line treatment
Combination of vinorelbine plus gemcitabine in previously treated patients with small cell lung cancer: A multicentre phase II study
Keywords: خط دوم درمان; Vinorelbine; Gemcitabine; Small cell lung cancer; Second-line treatment;
Role of Fulvestrant in Sequential Hormonal Therapy for Advanced, Hormone Receptor-Positive Breast Cancer in Postmenopausal Women
Keywords: خط دوم درمان; Antiestrogen; Second-line treatment; Sequencing; Third-line treatment;